1. Home
  2. PTHL vs ELUT Comparison

PTHL vs ELUT Comparison

Compare PTHL & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • ELUT
  • Stock Information
  • Founded
  • PTHL 1998
  • ELUT 2015
  • Country
  • PTHL China
  • ELUT United States
  • Employees
  • PTHL N/A
  • ELUT N/A
  • Industry
  • PTHL
  • ELUT Medical Specialities
  • Sector
  • PTHL
  • ELUT Health Care
  • Exchange
  • PTHL Nasdaq
  • ELUT Nasdaq
  • Market Cap
  • PTHL 85.4M
  • ELUT 71.5M
  • IPO Year
  • PTHL 2024
  • ELUT 2020
  • Fundamental
  • Price
  • PTHL $18.50
  • ELUT $2.11
  • Analyst Decision
  • PTHL
  • ELUT Strong Buy
  • Analyst Count
  • PTHL 0
  • ELUT 2
  • Target Price
  • PTHL N/A
  • ELUT $8.00
  • AVG Volume (30 Days)
  • PTHL 1.0M
  • ELUT 25.9K
  • Earning Date
  • PTHL 02-11-2025
  • ELUT 08-06-2025
  • Dividend Yield
  • PTHL N/A
  • ELUT N/A
  • EPS Growth
  • PTHL N/A
  • ELUT N/A
  • EPS
  • PTHL N/A
  • ELUT N/A
  • Revenue
  • PTHL $448,196.00
  • ELUT $23,711,000.00
  • Revenue This Year
  • PTHL N/A
  • ELUT $20.10
  • Revenue Next Year
  • PTHL N/A
  • ELUT $85.89
  • P/E Ratio
  • PTHL N/A
  • ELUT N/A
  • Revenue Growth
  • PTHL N/A
  • ELUT N/A
  • 52 Week Low
  • PTHL $1.32
  • ELUT $1.61
  • 52 Week High
  • PTHL $22.34
  • ELUT $5.24
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • ELUT 53.70
  • Support Level
  • PTHL N/A
  • ELUT $1.70
  • Resistance Level
  • PTHL N/A
  • ELUT $2.17
  • Average True Range (ATR)
  • PTHL 0.00
  • ELUT 0.15
  • MACD
  • PTHL 0.00
  • ELUT 0.03
  • Stochastic Oscillator
  • PTHL 0.00
  • ELUT 54.15

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: